BE904059A - Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques - Google Patents
Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiquesInfo
- Publication number
- BE904059A BE904059A BE0/216148A BE216148A BE904059A BE 904059 A BE904059 A BE 904059A BE 0/216148 A BE0/216148 A BE 0/216148A BE 216148 A BE216148 A BE 216148A BE 904059 A BE904059 A BE 904059A
- Authority
- BE
- Belgium
- Prior art keywords
- production
- salts
- pharmaceutical compositions
- treatment
- release
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- -1 lipid peroxides Chemical class 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 230000002132 lysosomal effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69230985A | 1985-01-17 | 1985-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE904059A true BE904059A (fr) | 1986-07-17 |
Family
ID=24780061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/216148A BE904059A (fr) | 1985-01-17 | 1986-01-17 | Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0201359A3 (OSRAM) |
| JP (2) | JPS61165327A (OSRAM) |
| BE (1) | BE904059A (OSRAM) |
| CH (2) | CH677731A5 (OSRAM) |
| FR (1) | FR2578164B1 (OSRAM) |
| IT (1) | IT1213024B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63270678A (ja) * | 1987-04-30 | 1988-11-08 | Mitsui Petrochem Ind Ltd | 新規含窒素化合物 |
| US20050049278A1 (en) * | 2003-08-27 | 2005-03-03 | Youssef Bennani | Benzo[1,3]dioxole compounds, pharmaceutical compositions thereof, and processes of making and using the same |
| CN101735229A (zh) * | 2009-12-24 | 2010-06-16 | 沈阳药科大学 | 四氢异喹啉类化合物及其制备方法和用途 |
| FR3111071B1 (fr) * | 2020-06-04 | 2023-01-13 | H4 Orphan Pharma | Utilisation de ligands multifonctionnels pour traiter les syndromes de détresse respiratoire et le choc cytokinique liés aux infections virales à coronavirus. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1206909B (de) * | 1959-08-14 | 1965-12-16 | Maurice Jeanson | Verfahren zur Herstellung von Inhibitoren der Histidindecarboxylase |
| FR2424271A1 (fr) * | 1978-04-28 | 1979-11-23 | Laire Chimie Sa De | Derives de phtalidyl-isoquinoleines, leur preparation et leur application comme medicaments |
| DE2964836D1 (en) * | 1979-10-22 | 1983-03-24 | Calaire Chimie Sa | Phthalide-isoquinoline derivatives, their preparation and their use in medicaments |
-
1986
- 1986-01-14 JP JP61006117A patent/JPS61165327A/ja active Pending
- 1986-01-14 JP JP61006118A patent/JPS61165326A/ja active Pending
- 1986-01-17 CH CH2174/88A patent/CH677731A5/fr not_active IP Right Cessation
- 1986-01-17 FR FR868600651A patent/FR2578164B1/fr not_active Expired - Lifetime
- 1986-01-17 CH CH167/86A patent/CH670642A5/fr not_active IP Right Cessation
- 1986-01-17 EP EP86400095A patent/EP0201359A3/en not_active Withdrawn
- 1986-01-17 BE BE0/216148A patent/BE904059A/fr not_active IP Right Cessation
- 1986-01-17 IT IT8619100A patent/IT1213024B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0201359A2 (en) | 1986-11-12 |
| IT8619100A0 (it) | 1986-01-17 |
| CH670642A5 (OSRAM) | 1989-06-30 |
| FR2578164B1 (fr) | 1990-08-10 |
| JPS61165327A (ja) | 1986-07-26 |
| IT1213024B (it) | 1989-12-07 |
| JPS61165326A (ja) | 1986-07-26 |
| CH677731A5 (en) | 1991-06-28 |
| FR2578164A1 (fr) | 1986-09-05 |
| EP0201359A3 (en) | 1989-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6593339B1 (en) | Use of compounds as antibacterial agents | |
| NO863620L (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
| EP0280999A2 (en) | Stabilized pharmaceutical compositions containing angiotensin-converting enzyme inhibitors | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| TNSN87012A1 (fr) | Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques | |
| KR970025615A (ko) | 암 전이 억제제 | |
| TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
| BE904196A (fr) | Preparations pharmaceutiques a activite analgesique, ainsi que leur fabrication et leur utilisation. | |
| TNSN89039A1 (fr) | Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales | |
| DZ1324A1 (fr) | Dérivés de céphalosporine, procédé pour leur préparation compositions pharmaceutiques les contenant et leur utilisation dans le traitement d'infections bactériennes. | |
| DK562488D0 (da) | Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater | |
| BE904059A (fr) | Utilisation de derives d'isoquinoleine et de leurs sels pour la production de compositions pharmaceutiques | |
| BE902796A (fr) | Ester d'acetyl carnitine, sa preparation et son utilisation. | |
| ES2066134T3 (es) | Usos farmaceuticos de acidos grasos. | |
| KR870007937A (ko) | 2β-치환된 티오 메틸페니실린 유도체 및 그의 제조방법 및 용도 | |
| EP0543855A1 (en) | Use of aryl hydroxyurea compounds for the treatment of atherosclerosis | |
| KR890004705A (ko) | 항바이러스성 제제 | |
| US4483854A (en) | Systemic treatment of psoriasis using certain salicylates | |
| EP0545805A1 (fr) | Utilisation de la D-fenfluramine et de dérivés de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-résistants | |
| FR2408589A1 (fr) | Nouvelles 13,14-bisdeshydroprostaglandines, leur procede de preparation et leurs applications therapeutiques | |
| BE1000719A4 (fr) | Derives de 3-(hydroxymethyl)-isoquinoleine, procede pour les preparer et compositions pharmaceutiques les contenant. | |
| BE900780A (fr) | DERIVES DE LA CHLORO-4-FURO (3,4-c)-PYRIDINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES DERIVES. | |
| US4663345A (en) | Etodolac for treatment of gout | |
| IT1228537B (it) | Derivati della cisteina ad azione espettorante | |
| FR2430767A1 (fr) | Nouvelles compositions pharmaceutiques a action hypotensive accrue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: MITSUBISHI HASEI CORP. Effective date: 19930131 |